Direct-acting oral anticoagulant or vitamin K antagonist for the frail elderly patient with atrial fibrillation
does one size fit all?
William A E Parker, Robert F Storey - European heart journal
This EHJ editorial discussed the choice between DOACs and vitamin K antagonists for frail elderly AF patients, reviewing the emerging evidence supporting safe transition to NOACs even in the most vulnerable anticoagulation population.
